Can starting a new rescue inhaler in the ER keep asthma patients out of the hospital?

NCT ID NCT07166939

Recruiting now Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving adults with acute asthma a specific rescue inhaler (Airsupra) right in the emergency department can reduce the chance of another asthma attack within 3 months. About 1,860 participants will either receive Airsupra or continue usual care. The goal is to see if early use of this inhaler leads to better asthma control and fewer urgent visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Airsupra (a combination inhaler for asthma rescue)
What this could lead to: If successful, this could show that starting Airsupra in the emergency department helps prevent asthma attacks and improves control after discharge.
What could go wrong: This is a phase 4 study, so Airsupra is already approved, but it may not significantly reduce asthma recurrence compared to usual care. Results depend on real-world adherence and may not apply to all asthma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute asthma asthma Emergencies status asthmaticus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA ASTHMA ACUTE ASTHMA CONTROL LEVEL ASTHMA EXACERBATION

Contacts and locations

Locations

MetroHealth
RECRUITING

Cleveland, Ohio, 44109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.